Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma.
Clement PMJ, Dirven L, Eoli M, Sepulveda-Sanchez JM, Walenkamp AME, Frenel JS, Franceschi E, Weller M, Chinot O, De Vos FYFL, Whenham N, Sanghera P, Looman J, Kundu MG, Peter de Geus J, Nuyens S, Spruyt M, Gorlia T, Coens C, Golfinopoulos V, Reijneveld JC, van den Bent MJ. Clement PMJ, et al. Among authors: reijneveld jc. Eur J Cancer. 2021 Apr;147:1-12. doi: 10.1016/j.ejca.2021.01.010. Epub 2021 Feb 15. Eur J Cancer. 2021. PMID: 33601293 Free article. Clinical Trial.
Decision-making in the end-of-life phase of high-grade glioma patients.
Sizoo EM, Pasman HR, Buttolo J, Heimans JJ, Klein M, Deliens L, Reijneveld JC, Taphoorn MJ. Sizoo EM, et al. Among authors: reijneveld jc. Eur J Cancer. 2012 Jan;48(2):226-32. doi: 10.1016/j.ejca.2011.11.010. Epub 2011 Dec 5. Eur J Cancer. 2012. PMID: 22153216 Free article.
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors.
Habets EJ, Taphoorn MJ, Nederend S, Klein M, Delgadillo D, Hoang-Xuan K, Bottomley A, Allgeier A, Seute T, Gijtenbeek AM, de Gans J, Enting RH, Tijssen CC, van den Bent MJ, Reijneveld JC. Habets EJ, et al. Among authors: reijneveld jc. J Neurooncol. 2014 Jan;116(1):161-8. doi: 10.1007/s11060-013-1278-0. Epub 2013 Oct 26. J Neurooncol. 2014. PMID: 24162809
The end-of-life phase of high-grade glioma patients: a systematic review.
Sizoo EM, Pasman HR, Dirven L, Marosi C, Grisold W, Stockhammer G, Egeter J, Grant R, Chang S, Heimans JJ, Deliens L, Reijneveld JC, Taphoorn MJ. Sizoo EM, et al. Among authors: reijneveld jc. Support Care Cancer. 2014 Mar;22(3):847-57. doi: 10.1007/s00520-013-2088-9. Epub 2013 Dec 14. Support Care Cancer. 2014. PMID: 24337718 Review.
Changing incidence and improved survival of gliomas.
Ho VK, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, Visser O; Dutch Society for Neuro-Oncology (LWNO). Ho VK, et al. Among authors: reijneveld jc. Eur J Cancer. 2014 Sep;50(13):2309-18. doi: 10.1016/j.ejca.2014.05.019. Epub 2014 Jun 24. Eur J Cancer. 2014. PMID: 24972545
The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review.
Dirven L, Taphoorn MJ, Reijneveld JC, Blazeby J, Jacobs M, Pusic A, La Sala E, Stupp R, Fayers P, Efficace F; EORTC Quality of Life Group (Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Registry). Dirven L, et al. Among authors: reijneveld jc. Eur J Cancer. 2014 Sep;50(14):2432-48. doi: 10.1016/j.ejca.2014.06.016. Epub 2014 Jul 14. Eur J Cancer. 2014. PMID: 25034656 Review.
230 results